To evaluate the efficacy of 2 grams per day of oral calcium supplementation in reducing the
combined incidence of hypertensive disorders of pregnancy: pre-eclampsia, eclampsia, and the
HELLP Syndrome (hypertension, thrombocytopenia, hemolysis, and abnormal liver function). The
National Institute of Child Health and Human Development (NICHD) initiated the trial in 1991,
with joint funding provided by the National Heart, Lung, and Blood Institute in fiscal years
1992, 1993, and 1995.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) National Heart, Lung, and Blood Institute (NHLBI)
Collaborator:
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)